Management of preterm labour


      Preterm birth is defined as birth before 37 weeks of gestation and is the single biggest cause of neonatal morbidity and mortality. The UK preterm birth rate has increased to 8.6% and this is despite advances in prediction of those at risk, prevention strategies and treatment. Transvaginal ultrasound and foetal fibronectin have been the major advances in the prediction of preterm labour, and with the use of both of these tests it may be possible to predict up to 75% of those who will deliver prematurely. At best, tocolytics are able to delay preterm labour long enough for the administration of corticosteroids. Labour involves complex and co-ordinated events, greater knowledge of which is necessary to understand processes involved in premature labour and advance healthcare in this field.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Further reading

        • Berghella V.
        • Hayes E.
        • Visintine J.
        • Baxter J.K.
        Fetal fibronectin testing for reducing the risk of preterm birth.
        Cochrane Database Syst Rev. 2008 Oct 8; : CD006843
        • Berghella V.
        • Baxter J.K.
        • Hendrix N.W.
        Cervical assessment by ultrasound for preventing preterm delivery.
        Cochrane Database Syst Rev. 2009 Jul 8; : CD007235
        • Costeloe K.
        • Hennessy E.
        • Gibson A.T.
        • Marlow N.
        • Wilkinson A.R.
        The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability.
        Pediatrics. October 2000; 106: 659-671
        • Goldenberg R.L.
        • Culhane J.F.
        • Iams J.D.
        • Romero R.
        Epidemiology and causes of preterm birth.
        Lancet. 2008 Jan 5; 371: 75-84
        • Kenyon S.
        • Pike K.
        • Jones D.R.
        • et al.
        Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial.
        Lancet. 2008 Oct 11; 372: 1319-1327
      1. Norman JE, Mackenzie F, Owen P, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet June 09; 373(9680): 2034–40.

        • Nuffield Council of Bioethics
        Critical care decisions in fetal and neonatal medicine: ethical issues.
        (published Thu 16 Nov 2006)
      2. RCOG Green top guidelines 1b preterm labour, tocolytic drugs. London: RCOG, Oct 2002.

      3. RCOG Green top guidelines 7 Respiratory Distress Syndrome, antenatal corticosteroids. London: RCOG, Feb 2004.

        • Rode L.
        • Langhoff-Roos J.
        • Andersson C.
        • et al.
        Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies.
        Acta Obstet Gynecol Scand. 2009; 88: 1180-1189